Stay updated on Emixustat in Stargardt Macular Atrophy Clinical Trial
Sign up to get notified when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.

Latest updates to the Emixustat in Stargardt Macular Atrophy Clinical Trial page
- Check2 days agoChange DetectedThe page revision/version marker was updated from **v3.5.2** to **v3.5.3**, indicating a maintenance or release update to the site’s display/versioning rather than a change to the underlying study information.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision: v3.5.2 added and revision: v3.5.0 removed. This appears to be a site maintenance update with no impact on the study information or page content.SummaryDifference0.1%

- Check17 days agoChange DetectedThe screenshots reflect a visual/layout refresh with no changes to core study content. Study details, eligibility criteria, and contact information appear unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the revision history.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision tag updated to v3.4.3; previous tag v3.4.2 was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 is now displayed, and the funding-status notice along with Revision: v3.4.1 text has been removed.SummaryDifference0.5%

Stay in the know with updates to Emixustat in Stargardt Macular Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.